APG Asset Management
TEVA icon

APG Asset Management’s Teva Pharmaceuticals TEVA Stock Holding History

APG Asset Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-73,038
Closed -$1.94M – 536
2025
Q4 		$1.94M Buy
73,038
+18,446
+34% +$454K 0.01% 512
2025
Q3 		$939K Buy
54,592
+4,772
+10% +$83.8K ﹤0.01% 512
2025
Q2 		$711K Buy
49,820
+3,155
+7% +$50.9K ﹤0.01% 521
2025
Q1 		$664K Sell
46,665
-22,229
-32% -$397K ﹤0.01% 526
2024
Q4 		$1.47M Sell
68,894
-64,301
-48% -$1.17M ﹤0.01% 515
2024
Q3 		$2.15M Sell
133,195
-1,136,201
-90% -$19.9M 0.01% 321
2024
Q2 		$19.2M Buy
1,269,396
+112,481
+10% +$1.73M 0.03% 331
2024
Q1 		$15.1M Buy
1,156,915
+155,953
+16% +$1.97M 0.03% 378
2023
Q4 		$9.46M Sell
1,000,962
-56,501
-5% -$528K 0.02% 407
2023
Q3 		$10.8M Sell
1,057,463
-99,666
-9% -$928K 0.02% 393
2023
Q2 		$7.99M Buy
1,157,129
+161,632
+16% +$1.31M 0.02% 438
2023
Q1 		$8.11M Sell
995,497
-160,133
-14% -$1.58M 0.02% 444
2022
Q4 		$10.5M Buy
1,155,630
+948,004
+457% +$8.27M 0.02% 445
2022
Q3 		$1.71M Buy
207,626
+59,754
+40% +$528K ﹤0.01% 569
2022
Q2 		$1.06M Sell
147,872
-946,594
-86% -$8.25M ﹤0.01% 643
2022
Q1 		$9.24M Buy
1,094,466
+6,910
+0.6% +$57.7K 0.02% 425
2021
Q4 		$7.66M Buy
1,087,556
+99,633
+10% +$899K 0.01% 455
2021
Q3 		$8.3M Sell
987,923
-450,000
-31% -$4.21M 0.01% 460
2021
Q2 		$12M Buy
1,437,923
+549,900
+62% +$5.82M 0.02% 457
2021
Q1 		$8.72M Buy
888,023
+219,700
+33% +$2.52M 0.01% 497
2020
Q4 		$5.27M Buy
668,323
+37,694
+6% +$361K 0.01% 634
2020
Q3 		$4.84M Sell
630,629
-61,200
-9% -$647K 0.01% 669
2020
Q2 		$7.59M Buy
691,829
+28,300
+4% +$320K 0.01% 617
2020
Q1 		$5.96M Buy
663,529
+625,469
+1,643% +$6.41M 0.01% 644
2019
Q4 		$332K Sell
38,060
-32,709
-46% -$292K ﹤0.01% 931
2019
Q3 		$447K Sell
70,769
-118,659
-63% -$909K ﹤0.01% 892
2019
Q2 		$1.53M Sell
189,428
-763,826
-80% -$9.21M ﹤0.01% 774
2019
Q1 		$13.3M Buy
953,254
+339,669
+55% +$5.99M 0.02% 447
2018
Q4 		$8.28M Buy
613,585
+469,295
+325% +$9.62M 0.02% 491
2018
Q3 		$2.68M Buy
144,290
+8,127
+6% +$189K ﹤0.01% 697
2018
Q2 		$2.84M Sell
136,163
-78,201
-36% -$1.59M 0.01% 677
2018
Q1 		$2.98M Hold
214,364
– – 0.01% 650
2017
Q4 		$3.38M Hold
214,364
– – 0.01% 682
2017
Q3 		$3.77M Buy
214,364
+145,581
+212% +$3.28M 0.01% 672
2017
Q2 		$2.29M Hold
68,783
– – ﹤0.01% 641
2017
Q1 		$2.21M Sell
68,783
-709,277
-91% -$24.2M ﹤0.01% 647
2016
Q4 		$26.7M Buy
778,060
+680,287
+696% +$27.2M 0.05% 369
2016
Q3 		$4.5M Buy
+97,773
New +$5.1M 0.01% 663

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

APG Asset Management's TEVA Position: Q1 2026 in Review

APG Asset Management sold out of Teva Pharmaceuticals (TEVA) in Q1 2026, closing a stake of 73,038 shares — an estimated $1.94M sold.

APG Asset Management first reported a position in TEVA in Q3 2016 and held it in 38 quarters. The position peaked at $26.7M in Q4 2016. 651 funds tracked by Wall St. Rank hold TEVA as of Q1 2026.

  • APG Asset Management reported no remaining Teva Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • APG Asset Management sold 73,038 Teva Pharmaceuticals shares in Q1 2026, an estimated $1.94M.
  • APG Asset Management first reported a position in Teva Pharmaceuticals in Q3 2016 and held it in 38 quarters.
  • APG Asset Management's Teva Pharmaceuticals position peaked at $26.7M in Q4 2016.
  • 651 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2026.

Based on APG Asset Management's 13F filing for Q1 2026, filed 13 May 2026.